This report provides a quantitative analysis of the sustainability goals of pharmaceutical industry leaders Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi and Teva. Published in 2011.
Goals signal intent and drive behavior. Some companies use public announcements of sustainability goals to signal their commitment to become sustainability leaders and to compete for superior positioning with their rivals. There has never been a convenient benchmarking tool to allow sustainability executives to put their own goals in the context of their competitors. Until now.
Purchase this report to learn:
- How do the pharma companies’ environmental sustainability goals compare?
- Which sustainability issues are receiving the greatest attention?
- Which companies are setting the most quantitative, forward-looking goals?
- And more.
Pages: 11; Figures: 5
Goals and Targets Drive Change and Competitive Differentiation
List of Goals
Figure 1 Breakdown of Sustainability Goals by Major Area
Figure 2 GSK’s carbon footprint in 2009 (% of CO2e)
Figure 3 Number of Sustainability Goals per Company by Target Year
Figure 4 Percentage of Goals Addressing Each Issue
Figure 5 List of Company Sustainability Goals